Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "mRNA-4157 (V940) Individualized Neoantigen Therapy + Pembro vs. Pembro in High-Risk Resected Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jeffrey Weber
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jeffrey Weber
193 views
November 1, 2023
Comments 0
Login to view comments.
Click here to Login
Skin